Infectious Diseases News

The CDC’s Advisory Committee on Immunization Practices unanimously voted to recommend respiratory syncytial virus vaccinations for all adults aged 75 years and older, as well as those aged 60 to 74 years at high risk for severe disease.

After decades of RSV vaccine development, the approvals and recommendations were seen as landmark events in preventive medicine. Uptake was low, however — not unusual for first-year approvals, experts told Healio.

Avian influenza continues to be detected among birds and dairy cows in the United States, raising questions about how to control the more than 2-year-old outbreak.

A novel combination of neuraminidase mutations detected in influenza A(H1N1)pdm09 viruses on several continents has left these viruses less susceptible to treatment with oseltamivir, researchers found.

The CDC on Thursday recommended updated COVID-19 vaccines for the 2024-2025 respiratory season, and a newly approved 21-valent pneumococcal conjugate vaccine for adults.

Patients receiving infectious diseases consultation over the past decade were increasingly complex, generally sicker and more likely to die soon after a consultation was performed.

The CDC’s vaccine advisors voted unanimously Wednesday to recommend that everyone aged 75 years or older get vaccinated against respiratory syncytial virus.

Children hospitalized with SARS-CoV-2 or an inflammatory syndrome associated with SARS-CoV-2 infection who experience severe neurological manifestations may be at a higher risk for long-term impairment, a study found.

A two-dose series of a hepatitis B vaccine with a CpG adjuvant resulted in a more than 90% response rate among health care workers previously classified as nonresponders, researchers found.

When it comes to screening perinatally exposed infants for hepatitis C virus, the earlier the better, a study showed.